Methods of treating cancer using PRMT5 inhibitors | Patent Number 11571437

US 11571437 B2
Application Number16893477
Publication NumberUS 20200384006 A1
Pendency2 years, 8 months, 7 days
Filled DateJun 5, 2020
Priority DateJun 6, 2019
Publication DateDec 10, 2020
Expiration DateJun 5, 2039
Inventor/ApplicantsYue Guo
Hillary Joy Millar Quinn
Kathryn Elizabeth Packman
Hong Xie
Josh Lauring
Geert S. J. Mannens
Anthony T. Greway
Geert S.J. Mannens
Dirk Brehmer
Junguo Zhou
Tongfei Wu
Nahor Haddish-Berhane
ExaminesCRAIGO, BAHAR ALAWI
Art Unit1759
Technology Center1700
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.